4//SEC Filing
Liu Yanjun 4
Accession 0001209191-19-049695
CIK 0001260990other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 5:42 PM ET
Size
5.7 KB
Accession
0001209191-19-049695
Insider Transaction Report
Form 4
Liu Yanjun
Director
Transactions
- Award
Stock Option
2019-09-12−30,000→ 30,000 totalExercise: $5.76Exp: 2029-09-12→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]One thirty-sixth of each Effective Date Award and each Initial Award shall vest and become exercisable in substantially equal installments on each monthly anniversary of the date of grant, so that the options subject to each such type of award shall be fully vested on the three-year anniversary of the date of grant, subject to the Reporting Persons continued service on the Board through each such vesting date.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001778086
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 5:42 PM ET
- Size
- 5.7 KB